Terms: = Germ cell tumor AND POU5F1, MGC22487, 5460, ENSG00000230336, POU5F1P1, OTF3P1, Oct4, OCT4, OCT3, OTF3C, OTF4, OTF3 AND Treatment
184 results:
1. Inhibition of PRMT1 Suppresses the Growth of U87MG-Derived Glioblastoma Stem cells by Blocking the STAT3 Signaling Pathway.
Yuk N; Jung HJ
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474197
[TBL] [Abstract] [Full Text] [Related]
2. Prognostic model for assessing the human glioma cell malignancy grade based on MDM2, MELK, SOX2, CDK4, DR5 and oct4 gene expression.
Tyagunova EE; Drozd SF; Kalennik OV; Samoylenkova NS; Savchenko EA; Danilov GV; Pavlova GV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):43-51. PubMed ID: 38054226
[TBL] [Abstract] [Full Text] [Related]
3. Dauricine attenuates oct4/sonic hedgehog co-activated stemness and induces reactive oxygen species-mediated mitochondrial apoptosis via AKT/β-catenin signaling in human neuroblastoma and glioblastoma stem-like cells.
Liu C; Yang T; Cheng C; Huo J; Peng X; Zhang Y
Phytother Res; 2024 Jan; 38(1):131-146. PubMed ID: 37821355
[TBL] [Abstract] [Full Text] [Related]
4. Human endogenous retrovirus K contributes to a stem cell niche in glioblastoma.
Shah AH; Rivas SR; Doucet-O'Hare TT; Govindarajan V; DeMarino C; Wang T; Ampie L; Zhang Y; Banasavadi-Siddegowda YK; Walbridge S; Maric D; Garcia-Montojo M; Suter RK; Lee MH; Zaghloul KA; Steiner J; Elkahloun AG; Chandar J; Seetharam D; Desgraves J; Li W; Johnson K; Ivan ME; Komotar RJ; Gilbert MR; Heiss JD; Nath A
J Clin Invest; 2023 Jul; 133(13):. PubMed ID: 37395282
[TBL] [Abstract] [Full Text] [Related]
5. Suppression of NANOG Expression Reduces Drug Resistance of Cancer Stem cells in Glioblastoma.
Smith J; Field M; Sugaya K
Genes (Basel); 2023 Jun; 14(6):. PubMed ID: 37372456
[TBL] [Abstract] [Full Text] [Related]
6. Inhibition of PIM Kinases Promotes Neuroblastoma cell Differentiation to a Neuronal Phenotype.
Julson JR; Quinn CH; Bownes LV; Hutchins SC; Stewart JE; Aye J; Yoon KJ; Beierle EA
J Pediatr Surg; 2023 Jun; 58(6):1155-1163. PubMed ID: 36907773
[TBL] [Abstract] [Full Text] [Related]
7. Generation of mesenchymal stromal cells from urine-derived iPSCs of pediatric brain tumor patients.
Baliña-Sánchez C; Aguilera Y; Adán N; Sierra-Párraga JM; Olmedo-Moreno L; Panadero-Morón C; Cabello-Laureano R; Márquez-Vega C; Martín-Montalvo A; Capilla-González V
Front Immunol; 2023; 14():1022676. PubMed ID: 36776860
[TBL] [Abstract] [Full Text] [Related]
8. WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma.
Mitchell K; Sprowls SA; Arora S; Shakya S; Silver DJ; Goins CM; Wallace L; Roversi G; Schafer RE; Kay K; Miller TE; Lauko A; Bassett J; Kashyap A; D'Amato Kass J; Mulkearns-Hubert EE; Johnson S; Alvarado J; Rich JN; Holland EC; Paddison PJ; Patel AP; Stauffer SR; Hubert CG; Lathia JD
Genes Dev; 2023 Feb; 37(3-4):86-102. PubMed ID: 36732025
[TBL] [Abstract] [Full Text] [Related]
9. Volumetric changes in gray matter after radiotherapy detected with longitudinal magnetic resonance imaging in glioma patients.
Lee HI; Kang MK; Hwang K; Kim CY; Kim YJ; Suh KJ; Choi BS; Choe G; Kim IA; Jang BS
Radiother Oncol; 2022 Nov; 176():157-164. PubMed ID: 36208651
[TBL] [Abstract] [Full Text] [Related]
10. Propofol enhances stem-like properties of glioma via GABA
Fan X; Gong M; Yu H; Yang H; Wang S; Wang R
Stem Cell Res Ther; 2022 Aug; 13(1):398. PubMed ID: 35927718
[TBL] [Abstract] [Full Text] [Related]
11. Organic cation transporter 3 mediates the non-norepinephrine transporter driven uptake of meta-[
Ohshima Y; Sasaki I; Watanabe S; Sakashita T; Higashi T; Ishioka NS
Nucl Med Biol; 2022; 112-113():44-51. PubMed ID: 35802985
[TBL] [Abstract] [Full Text] [Related]
12. The impact of temozolomide and lonafarnib on the stemness marker expression of glioblastoma cells in multicellular spheroids.
Nakod PS; Kondapaneni RV; Edney B; Kim Y; Rao SS
Biotechnol Prog; 2022 Sep; 38(5):e3284. PubMed ID: 35768943
[TBL] [Abstract] [Full Text] [Related]
13. Chelerythrine Chloride Inhibits Stemness of Melanoma Cancer Stem-Like cells (CSCs) Potentially via Inducing Reactive Oxygen Species and Causing Mitochondria Dysfunction.
Li H; He M; Zhao P; Liu P; Chen W; Xu X
Comput Math Methods Med; 2022; 2022():4000733. PubMed ID: 35761835
[TBL] [Abstract] [Full Text] [Related]
14. oct4A palmitoylation modulates tumorigenicity and stemness in human glioblastoma cells.
Chen X; Niu W; Fan X; Yang H; Zhao C; Fan J; Yao X; Fang Z
Neuro Oncol; 2023 Jan; 25(1):82-96. PubMed ID: 35727735
[TBL] [Abstract] [Full Text] [Related]
15. Addiction of Merkel cell carcinoma to MUC1-C identifies a potential new target for treatment.
Morimoto Y; Fushimi A; Yamashita N; Hagiwara M; Bhattacharya A; Cheng J; Frost TC; Ahmad R; Daimon T; Huang L; Hata T; Takahashi H; Yamamoto M; Suzuki Y; DeCaprio JA; Kufe D
Oncogene; 2022 Jul; 41(27):3511-3523. PubMed ID: 35688945
[TBL] [Abstract] [Full Text] [Related]
16. Clinicopathologic features and proposed grossing protocol of orchiectomy specimens performed for gender affirmation surgery.
Cornejo KM; Oliva E; Crotty R; Sadow PM; Devins K; Wintner A; Wu CL
Hum Pathol; 2022 Sep; 127():21-27. PubMed ID: 35660072
[TBL] [Abstract] [Full Text] [Related]
17. Overexpression of FOXD2-AS1 enhances proliferation and impairs differentiation of glioma stem cells by activating the NOTCH pathway via TAF-1.
Wang Y; Cheng Y; Yang Q; Kuang L; Liu G
J Cell Mol Med; 2022 May; 26(9):2620-2632. PubMed ID: 35419917
[TBL] [Abstract] [Full Text] [Related]
18. GABA
Kaushik I; Srivastava SK
Mol Ther; 2022 Jul; 30(7):2584-2602. PubMed ID: 35331907
[TBL] [Abstract] [Full Text] [Related]
19. The NOP14 nucleolar protein suppresses the function and stemness of melanoma stem-like cells through Wnt/beta-catenin signaling inactivation.
Li J; Fang R; Wu J; Si Y; Bai J; Wang Q
Bioengineered; 2022 Mar; 13(3):7648-7658. PubMed ID: 35282769
[TBL] [Abstract] [Full Text] [Related]
20. Patient-individual phenotypes of glioblastoma stem cells are conserved in culture and associate with radioresistance, brain infiltration and patient prognosis.
Ganser K; Eckert F; Riedel A; Stransky N; Paulsen F; Noell S; Krueger M; Schittenhelm J; Beck-Wödl S; Zips D; Ruth P; Huber SM; Klumpp L
Int J Cancer; 2022 May; 150(10):1722-1733. PubMed ID: 35085407
[TBL] [Abstract] [Full Text] [Related]
[Next]
